In This Section

San Antonio Breast Cancer Symposium 2024

The 2024 San Antonio Breast Cancer Symposium, hosted by UT Health San Antonio and the American Association for Cancer Research, took place from December 10-13, 2024. The symposium featured the latest research in the prevention, diagnosis, and treatment of premalignant breast disease and breast cancer, including data from late-breaking clinical trials. Each year, the symposium attracts thousands of basic scientists, physician-scientists, clinical investigators, breast care providers, and advocates from around the world.

mEDIA cOVERAGE

See highlights of media coverage featuring research presented at the San Antonio Breast Cancer Symposium 2024 below.

The Wall Street Journal The Emerging Breast-Cancer Treatment: No Surgery Required

Learn More

The Associated Press Some breast cancer patients can avoid certain surgeries, studies suggest

Learn More

STAT Pfizer’s blockbuster Ibrance slows tumor progression in another type of breast cancer

Learn More

Healio Olaparib confers durable benefit in BRCA-mutated breast cancer

Learn More

MedPage Today Oral SERD Impresses in Advanced Breast Cancer With ESR1 Mutations

Learn More

The ASCO Post Award Recipients Announced for the 2024 San Antonio Breast Cancer Symposium

Learn More
Press Program and Press Conferences

Read the press releases and watch the press conferences from the meeting’s official press program.

Learn More